In connection with the IPO on June 12, 2025 (“effective date”), the Company adopted the 2025 Incentive Award Plan (“2025 Plan”), under which the Company may grant cash and equity-based incentive awards which include, but are not limited to, Restricted Stock Awards (“RSAs”), Restricted Stock Units (“RSUs”) and Stock Options to employees, directors and consultants to the Company or its subsidiaries.

The aggregate number of shares of Class A common stock or Class B common stock, if determined by the plan administrator, available for issuance under the 2025 Plan as of the effective date of the 2025 Plan was 5.4 million shares. The amount of shares available for issuance is eligible to increase on the first day of each calendar year beginning January 1, 2026 and ending on and including January 1, 2035 by the lesser of (i) 5% of the shares of Class A common stock and Class B common stock outstanding on an as-converted basis on the last day of the immediately preceding fiscal year and (ii) such lesser amount as determined by the Company’s Board of Directors. As of June 30, 2026, approximately 6.7 million shares were available for future grants under the 2025 Plan.


	RSA Awards	Weighted-Average Grant Date Fair Value
Nonvested RSAs outstanding as of December 31, 2025	879,782	$	30.70
Issued	3,000	28.66
Vested	(28,576)	23.08
Forfeited	(17,750)	31.00
Nonvested RSAs outstanding as of March 31, 2026	836,456	$	30.89
Issued	28,250	26.76
Vested	(22,354)	30.59
Forfeited	(124,674)	30.91
Nonvested RSAs outstanding as of June 30, 2026	717,678	$	30.80

The RSAs granted during the six months ended June 30, 2026 have service-only vesting conditions and vest over a three-year service period beginning after the first year of service. All RSAs granted to employees are considered legally issued and outstanding for voting purposes. However, for accounting and dilution purposes, only vested awards are considered issued and outstanding.

Stock-based compensation expense related to RSAs for the three and six months ended June 30, 2026 was $1.0 million and $2.6 million, respectively. Stock-based compensation expense related to RSAs for each of the three and six months ended June 30, 2025 was $0.3 million.


	RSU Awards	Weighted-Average Grant Date Fair Value
Nonvested RSUs outstanding as of December 31, 2025	168,624	$	22.42
Issued	173,976	30.24
Vested	(19,130)	26.41
Forfeited	—	—
Nonvested RSUs outstanding as of March 31, 2026	323,470	$	26.34
Issued	138,468	32.06
Vested	(1,913)	31.33
Forfeited	(3,411)	27.18
Nonvested RSUs outstanding as of June 30, 2026	456,614	$	29.06

Stock-based compensation expense related to RSUs for the three and six months ended June 30, 2026 was $0.9 million and $1.6 million, respectively. There was no stock-based compensation expense related to RSUs for the three and six months ended June 30, 2025.

The Company has granted options under the 2020 Incentive Award Plan; however, following the effectiveness of the 2025 Plan, no further grants will be made under the 2020 Plan. During the six months ended June 30, 2026, the Company issued additional stock options under the 2025 Plan with terms materially consistent with those previously issued under the 2020 Plan.


	Number of Shares	Weighted-Average Exercise Price		Weighted-Average Grant Date Fair value		Weighted-Average Remaining Contractual Term (Years)
Outstanding as of December 31, 2025	4,595,417	$	15.34	$	8.68	7.6
Granted	353,050	30.53		20.60		10.0
Forfeited	(44,063)	21.57		16.43
Exercised	(325,037)	11.21		6.33
Outstanding as of March 31, 2026	4,579,367	$	15.36	$	10.85	7.2
Granted	27,729	35.08		23.94		10.0
Forfeited	(156,342)	23.97		16.93
Exercised	(368,538)	13.26		7.34
Outstanding as of June 30, 2026	4,082,216	$	16.85	$	9.83	7.3
Vested and exercisable as of June 30, 2026	2,907,323	$	12.74	$	5.97	6.6
Nonvested as of June 30, 2026	1,174,893	$	26.99	$	19.33	9.0